Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Daboia siamensis venom metalloproteinases (DsSVMPs) are a diverse group of zinc-dependent enzymes that constitute a major toxic component of the Eastern Russell's viper venom (UniProt, 2023). These enzymes are classified into different groups, primarily P-I and P-III, based on their domain structure, which includes metalloproteinase, disintegrin-like, and cysteine-rich domains (PubMed, PMID: 28235531). Their primary biological role in envenomation is the degradation of the extracellular matrix, specifically targeting the basement membrane of vascular endothelial cells, which results in profuse local and systemic hemorrhage (PubMed, PMID: 30145355). Furthermore, certain DsSVMPs act as potent procoagulants by activating Factor X or prothrombin, leading to venom-induced consumption coagulopathy (VICC) and potentially fatal bleeding (NIH, 2022). In the context of drug development, DsSVMPs are targeted by small-molecule inhibitors such as batimastat and marimastat, which bind the catalytic zinc ion, as well as metal chelators like unithiol (DMPS) (PubMed, PMID: 32824330). These therapeutic strategies aim to supplement traditional antivenom therapy, which can sometimes struggle to neutralize the rapid tissue-damaging effects of these enzymes.
Inhibition of enzymatic activity through zinc ion chelation at the catalytic site or competitive inhibition of the substrate-binding pocket.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Daboia siamensis venom metalloproteinase (DsSVMP).